Is a complete MBRX research report available?

No complete published report is available for Moleculin Biotech, Inc. (MBRX) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Moleculin Biotech, Inc. (MBRX)

NASDAQ: MBRX · USD

$1.02

-0.34 (-25.0%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first MBRX analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	5.4M
Net income (ttm)	-42.4M
EPS (ttm)	-$20.0
Shares out	5.3M
Volume	1,583,370
Beta	1.75
Price target	$21.0	+1958.8%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -42.4M
EPS (ttm): -$20.0
Market cap: 5.4M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All MBRX indicators

Market & fundamental data

Available fields

184

Groups with data

Currency

USD

Showing 184 of 184 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001659617
Company name	Moleculin Biotech, Inc.
Country	United States
Country code	US
Cusip	60855D408
Employees	17
Employees Change	-1%
Employees Change Percent	-5.56
Enterprise value	$-3.8M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2016-06-02
Isin	US60855D4088
Last refreshed	2026-07-31
Market cap	$5.4M
Market cap category	Nano-Cap
Price	$1.02
Price currency	USD
Sector	Healthcare
Sector PE	45.51
Sector PE Fwd	24.23
Sic	2834
Symbol	MBRX
Website	https://moleculin.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-687.44%
FCF yield	-393.97%
P/B ratio	0.48x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-42.4M
Net Income Growth Years	0%
Profit Per Employee	$-2.5M
ROA	-76.15
Roa5y	-46.38
ROCE	-175.5
ROE	-532
Roe5y	-109.8
ROIC	-211.2

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-61.88%
Cagr1y	-94.3%
Cagr3y	-83.97%
Cagr5y	-75.7%
EPS Growth Quarters	9
EPS Growth Years	3
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$23.4M
Cash	$10.3M
Current Assets	$11M
Current Liabilities	$8M
Debt	$326,000
Debt Equity	$0.02
Equity	$15.2M
Liabilities	$8.2M
Long Term Assets	$12.4M
Long Term Liabilities	$218,000
Net Cash	$10M
Net Cash By Market Cap	$162
Net Cash Growth	37.5%
Net Debt Equity	$-0.66
Tangible Book Value	$4M
Tangible Book Value Per Share	$0.76
WACC	13.18

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.38
Net Working Capital	$-7.2M
Quick ratio	1.3
Working Capital	$3M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-927.75%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-99.99%
1Y total return	-94.29%
200-day SMA	4.52
3Y total return	-99.59%
50-day SMA	2.47
50-day SMA vs 200-day SMA	50under200
5Y total return	-99.92%
All Time High	21,555
All Time High Change	-100%
All Time High Date	2016-06-06
All Time Low	1.01
All Time Low Change	0.99%
All Time Low Date	2026-07-30
ATR	0.24
Beta	1.75
Beta1y	-1.35
Beta2y	1.4
Ch YTD	-69.18
High	1.34
High52	18.75
High52 Date	2025-07-30
High52ch	-94.56%
Low	1.01
Low52	1.01
Low52 Date	2026-07-30
Low52ch	0.99%
Ma50ch	-58.67%
Premarket Change Percent	-1.47
Premarket Price	$1.34
Premarket Volume	26,098
Price vs 200-day SMA	-77.41%
RSI	21.24
RSI Monthly	29.65
RSI Weekly	31.35
Sharpe ratio	-1.9x
Sortino ratio	-2.11
Total Return	-927.75%
Tr YTD	-69.18
Tr1m	-71.43%
Tr1w	-50.96%
Tr3m	-59.36%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	3
Analyst Count Top	0
Analyst Ratings	Strong Buy
Earnings EPS Estimate	$-1.59
Operating Income	$-27M
Price target	$21
Price Target Change	$1,959

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	5,291,294%
Float Percent	99.16%
Shares Insiders	0.84%
Shares Institutions	4.12%
Shares Out	5,336,350
Shares Qo Q	84.21%
Shares Yo Y	927.75%
Short Float	19.93%
Short Ratio	0.97
Short Shares	19.76

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-25.8M
Adjusted OCF	-25,841,000
Average Volume	293,447.05x
Bv Per Share	2.85
Ch10y	-99.99
Ch1m	-71.43
Ch1w	-50.96
Ch1y	-94.29
Ch3m	-59.36
Ch3y	-99.59
Ch5y	-99.92
Ch6m	-76.17
Change	-25%
Change From Open	-23.88
Close	1.36
Days Gap	-1.47
Depreciation Amortization	67,000
Dollar Volume	1,615,037.4
Earnings Date	2026-08-12
Earnings Time	amc
EBIT	$-27M
EBITDA	$-27M
EPS	$-19.96
F Score	2
FCF	$-24.3M
FCF EV Yield	634.41x
FCF Per Share	$-4.55
Financing CF	26,897,000
Fiscal Year End	December
Founded	2,015
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-15
Last Report Date	2026-03-31
Last Split Date	2025-12-01
Last Split Type	Reverse
Last10k Filing Date	2026-03-18
Ma150	2.85
Ma150ch	-64.22%
Ma20	2.14
Ma20ch	-52.38%
Net CF	2,601,000
Next Earnings Date	2026-08-11
Open	1.34
Optionable	No
Position In Range	3.03
Post Close	1.02
Postmarket Change Percent	1.67
Postmarket Price	$1.04
Ppne	354,000
Pre Close	1.36
Price Date	2026-07-30
Ptbv Ratio	1.53
Relative Volume	5.47x
Share Based Comp	1,559,000
Tr6m	-76.17%
Us State	Texas
Volume	1,583,370

Moleculin Biotech, Inc. (MBRX)

Coverage state: Market snapshot only — no published research

Generate the first MBRX analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · MBRX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All MBRX indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on MBRX

Frequently asked questions